INmune Bio Inc. (NASDAQ: INMB) Stock Information | RedChip

INmune Bio Inc. (NASDAQ: INMB) Listen to this Section


$7.11
+0.2400 ( +3.49% ) 186.4K

INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.

Market Data


Open


$7.11

Previous close


$6.87

Volume


186.4K

Market cap


$141.05M

Day range


$6.87 - $7.48

52 week range


$6.50 - $14.74

Insider Ownership Transactions

Total Amount Purchased: -515,382.00 | $ -3,664,366.02

Date Type Amount Purchased Purchaser
2024-06-26 Buy 5000.00 Juda Scott
2024-06-12 Sale -37882.00 Tesi Raymond Joseph
2024-05-16 Sale -12500.00 Schroeder Timothy j
2024-05-16 Sale -100000.00 Lowdell Mark William
2024-05-16 Sale -12500.00 Juda Scott
2024-05-16 Sale -12500.00 Ganjei James Kelly
2024-05-16 Sale -12500.00 Baracchini Edgardo Jr
2024-05-16 Sale -12500.00 ALLEN MARCIA
2024-05-16 Sale -160000.00 Tesi Raymond Joseph
2024-05-16 Sale -160000.00 Moss David J

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 16 Aug 09, 2024
8-k 8K-related 15 Aug 02, 2024
10-q Quarterly Reports 65 Aug 01, 2024
8-k 8K-related 14 Jul 30, 2024
8-k 8K-related 13 Jul 19, 2024
8-k 8K-related 13 Jul 05, 2024
8-k 8K-related 14 Jul 01, 2024
4 Insider transactions 1 Jun 26, 2024
8-k 8K-related 14 Jun 13, 2024
4 Insider transactions 1 Jun 12, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.